Konstantinos Zarogoulidis Selected Research

Talc

5/2019	Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial.
5/2016	A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Zarogoulidis Research Topics

Disease

36	Neoplasms (Cancer) 02/2020 - 01/2012
29	Lung Neoplasms (Lung Cancer) 02/2020 - 01/2012
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2012
10	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2012
7	Carcinoma (Carcinomatosis) 11/2016 - 01/2013
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2013
6	Disease Progression 01/2019 - 01/2013
6	Carcinogenesis 08/2015 - 01/2014
6	Infections 03/2015 - 11/2012
5	Inflammation (Inflammations) 06/2017 - 11/2012
5	Carcinoid Tumor (Carcinoid) 01/2014 - 01/2012
4	Pneumothorax 03/2015 - 03/2014
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 01/2013
4	Pulmonary Hypertension 01/2014 - 01/2011
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2015
3	Pain (Aches) 01/2018 - 09/2013
3	Dyspnea (Shortness of Breath) 01/2018 - 01/2015
3	Asthma (Bronchial Asthma) 06/2017 - 01/2013
3	Postoperative Pain 01/2016 - 11/2012
3	Adenocarcinoma 02/2015 - 01/2013
3	Melanoma (Melanoma, Malignant) 01/2015 - 01/2014
3	Tracheal Stenosis 09/2013 - 11/2012
2	Necrosis 01/2018 - 05/2014
2	Fatigue 01/2018 - 01/2013
2	Pleural Effusion (Pleural Effusions) 05/2016 - 01/2014
2	Airway Obstruction (Choking) 01/2016 - 11/2012
2	Hyperhidrosis 09/2015 - 02/2015
2	Wounds and Injuries (Trauma) 03/2015 - 11/2012
2	Pulmonary Atelectasis 02/2015 - 02/2015
2	Surgical Wound 02/2015 - 03/2014
2	Pneumonia (Pneumonitis) 02/2015 - 06/2011
2	Tracheomalacia 01/2015 - 08/2013
2	Hemoptysis 10/2014 - 05/2013
2	Stroke (Strokes) 03/2014 - 03/2014
2	Coronary Disease (Coronary Heart Disease) 03/2014 - 08/2013
2	Hemorrhage 03/2014 - 01/2013
2	Granuloma 09/2013 - 08/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2013 - 01/2013
2	Lung Diseases (Lung Disease) 02/2013 - 01/2013
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2013 - 01/2013
1	Malignant Pleural Effusion 05/2019
1	Hyperthermia 05/2019

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 03/2015 - 10/2012
6	PlatinumIBA 01/2017 - 01/2013
5	ErbB Receptors (EGF Receptor)IBA 06/2018 - 01/2013
5	AerosolsIBA 01/2014 - 01/2012
4	Carboplatin (JM8)FDA LinkGeneric 02/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
4	Cytotoxins (Cytolysins)IBA 01/2016 - 08/2013
4	Biological ProductsIBA 01/2015 - 01/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2015 - 08/2013
4	Tyrosine Kinase InhibitorsIBA 01/2015 - 04/2013
4	CytokinesIBA 01/2015 - 08/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 01/2013
3	Indicators and Reagents (Reagents)IBA 11/2016 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 02/2020 - 01/2015
2	Talc FDA Link 05/2019 - 05/2016
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 01/2015
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2019 - 01/2015
2	InterleukinsIBA 01/2018 - 06/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 06/2011
2	Carbon MonoxideIBA 01/2015 - 12/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 08/2013
2	Sirolimus (Rapamycin)FDA Link 05/2014 - 09/2013
2	Moxifloxacin (Avelox)FDA Link 01/2014 - 10/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 01/2013
2	Insulin (Novolin)FDA Link 08/2013 - 01/2013
2	ProstaglandinsIBA 01/2013 - 01/2011
1	Pyruvic Acid (Pyruvate)IBA 02/2020
1	AntigensIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	human telomerase reverse transcriptase p572YIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Chromogranin AIBA 01/2019
1	technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotideIBA 01/2019
1	Insulin-Like PeptidesIBA 01/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2018

Therapy/Procedure

32	Therapeutics 01/2018 - 01/2012
28	Drug Therapy (Chemotherapy) 05/2019 - 01/2012
8	Radiotherapy 12/2016 - 09/2013
5	Thoracotomy 01/2016 - 11/2012
4	Stents 01/2015 - 11/2012
3	Immunotherapy 01/2020 - 01/2013
3	Pleurodesis 05/2019 - 09/2013
3	Conservative Treatment 03/2014 - 01/2012
2	Aftercare (After-Treatment) 01/2018 - 01/2011
2	Tracheostomy 01/2016 - 11/2012
2	Length of Stay 01/2016 - 03/2015
2	Sympathectomy (Sympathectomies) 09/2015 - 02/2015
2	Catheters 03/2015 - 09/2013
2	Bronchoscopes 02/2015 - 05/2013
2	Operative Surgical Procedures 02/2015 - 03/2014
2	Artificial Respiration (Mechanical Ventilation) 02/2015 - 11/2012
2	Decompression 02/2015 - 11/2012
2	Extracorporeal Circulation 03/2014 - 03/2014
2	Sternotomy 09/2013 - 11/2012
1	Maintenance Chemotherapy 01/2020